AMARIN

amarin-logo

Amarin Corporation is a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease. Amarin’s lead candidate, AMR101, is currently being studied in two concurrently run pivotal Phase 3 trials. These trials are investigating the efficacy of AMR101 in lowering triglycerides in patients with very high triglycerides (>500mg/dl) and in patients with mixed dyslipidemia who are taking statins. Amarin’s cardiovascular programs capitalize on Amarin'... s expertise in the field of lipid science and the known therapeutic benefits of essential fatty acids in treating cardiovascular disease. Amarin is headquartered in Dublin, Ireland, and has its research and development headquartered in Mystic Connecticut, USA. Amarin is listed in the U.S. on NASDAQ (ticker: AMRN)

#SimilarOrganizations #People #Financial #Event #Website #More

AMARIN

Social Links:

Industry:
Biopharma Biotechnology Health Care Pharmaceutical

Founded:
1991-01-01

Address:
Ballsbridge, Dublin, Ireland

Country:
Ireland

Website Url:
http://www.amarincorp.com

Total Employee:
101+

Status:
Active

Contact:
+353 1 669 9020

Email Addresses:
[email protected]

Total Funding:
227.82 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Tag Manager LetsEncrypt Cloudflare Hosting Apache Cloudflare JS CDN JS Pound Sterling


Similar Organizations

arbutus-biopharma-logo

Arbutus Biopharma

Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.

curevac-logo

CureVac

CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.

cytokinetics-logo

Cytokinetics

Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.

faron-pharmaceuticals-logo

Faron Pharmaceuticals

Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.

phasebio-pharmaceuticals-logo

PhaseBio Pharmaceuticals

PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

sparrow-pharmaceuticals-logo

Sparrow Pharmaceuticals

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.


Current Advisors List

kristine-peterson_image

Kristine Peterson Board Member @ Amarin
Board_member

eric-aguiar_image

Eric Aguiar Boards @ Amarin
Board_member

lars-ekman_image

Lars Ekman Board of Directors @ Amarin
Board_member

james-healy_image

James Healy Board of Directors @ Amarin
Board_member

not_available_image

Patrick O'Sullivan Member of Board of Directors @ Amarin
Board_member

james-healy_image

James Healy Board of Director @ Amarin
Board_member

joseph-zakrzewski_image

Joseph Zakrzewski Board Member @ Amarin
Board_member
2009-12-01

Current Employees Featured

patrick-holt_image

Patrick Holt
Patrick Holt President & Chief Executive Officer @ Amarin
President & Chief Executive Officer
2023-07-01

dan-s-dunham_image

Dan S. Dunham
Dan S. Dunham Chief Pharmaceutical Compliance Officer & SVP @ Amarin
Chief Pharmaceutical Compliance Officer & SVP

derek-kalinowski_image

Derek Kalinowski
Derek Kalinowski SVP of Commercial Supply Chain and Manufacturing Operations @ Amarin
SVP of Commercial Supply Chain and Manufacturing Operations

aaron-berg_image

Aaron Berg
Aaron Berg Senior Vice President, Chief Commercial Officer @ Amarin
Senior Vice President, Chief Commercial Officer
2018-04-01

aaron-berg_image

Aaron Berg
Aaron Berg Senior Vice President @ Amarin
Senior Vice President
2014-01-01

steven-ketchum_image

Steven Ketchum
Steven Ketchum SVP, President of R&D and Chief Scientific Officer @ Amarin
SVP, President of R&D and Chief Scientific Officer

aaron-berg_image

Aaron Berg
Aaron Berg Vice President @ Amarin
Vice President
2012-11-01

aaron-berg_image

Aaron Berg
Aaron Berg EVP & President @ Amarin
EVP & President
2021-08-01

angelos-baxevanis_image

Angelos Baxevanis
Angelos Baxevanis Head of Strategy and Transformation, Europe @ Amarin
Head of Strategy and Transformation, Europe
2021-12-01

rami-daoud_image

Rami Daoud
Rami Daoud SVP of Corporate Development @ Amarin
SVP of Corporate Development

Founder


not_available_image

Chukiat Utakapan

Stock Details


Company's stock symbol is NASDAQ:AMRN

Acquisitions List

Date Company Article Price
2007-12-05 Ester Neurosciences Ester Neurosciences acquired by Amarin N/A

Investors List

abingworth-management_image

Abingworth

Abingworth investment in Post-IPO Equity - Amarin

fountain-healthcare-partners_image

Fountain Healthcare Partners

Fountain Healthcare Partners investment in Post-IPO Equity - Amarin

orbimed-advisors_image

OrbiMed

OrbiMed investment in Post-IPO Equity - Amarin

longitude-capital_image

Longitude Capital

Longitude Capital investment in Post-IPO Equity - Amarin

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Post-IPO Equity - Amarin

Newest Events participated

12th-annual-cardiometabolic-health-congress_event_image Participated in 12th Annual Cardiometabolic Health Congress on 2017-10-04 as exhibitor

Official Site Inspections

http://www.amarincorp.com Semrush global rank: 3.41 M Semrush visits lastest month: 4.03 K

  • Host name: 172.66.135.113
  • IP address: 172.66.135.113
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Amarin"

Amarin Corporation - Wikipedia

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid. See details»

Amarin Corporation - LinkedIn

Amarin Corporation | 32,329 followers on LinkedIn. Amarin Corporation plc is a biopharmaceutical company focused on therapeutics to improve cardiovascular health. | Amarin is an innovative ...See details»

Amarin Company Profile - Office Locations, Competitors, Revenue …

Oct 29, 2024 Amarin has 5 employees across 3 locations and $306.91 m in annual revenue in FY 2023. See insights on Amarin including office locations, competitors, revenue, financials, …See details»

Amarin - Crunchbase Company Profile & Funding

Amarin Corporation is a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease. Amarin’s lead candidate, AMR101, is currently being studied in two concurrently run pivotal Phase 3 trials.See details»

Amarin Corporation - Overview, News & Similar companies

Jun 3, 2024 Amarin Corporation contact info: Phone number: +353 16699020 Website: www.amarincorp.com What does Amarin Corporation do? Founded in 1991, Amarin …See details»

Amarin Implements Organizational Restructuring to

Jul 18, 2023 The conference call can be accessed on the investor relations section of the Company's website at www.amarincorp.com, or via telephone by dialing 888-506-0062 within …See details»

Amarin Implements Organizational Restructuring to Strengthen …

Jul 18, 2023 Amarin Corporation plc-- Focus on Gaining Access for European Patients in Remaining Geographies and Strategic Use of Commercial Resources ---- Maximizes Cash …See details»

Amarin Pharma - Crunchbase Company Profile

Amarin Pharma is a pharmaceutical manufacturing. They creates a new paradigm in cardiovascular disease management and is positioned to address cardiovascular risk for millions of patients globally.See details»

Amarin Implements Organizational Restructuring to Strengthen …

Jul 18, 2023 The conference call can be accessed on the investor relations section of the Company's website at www.amarincorp.com, or via telephone by dialing 888-506-0062 within …See details»

AMARIN IMPLEMENTS ORGANIZATIONAL RESTRUCTURING TO …

Jul 19, 2023 Amarin's refocused strategic priorities and restructuring plan focuses on three core areas: Maximizing U.S. Cash Flow Through Streamlined Model: Amarin will maintain …See details»

Amarin Names Aaron Berg Interim President & Chief Executive …

Apr 17, 2023 DUBLIN, Ireland and BRIDGEWATER, N.J., April 17, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company’s Board of …See details»

Amarin Names Aaron Berg Interim President & Chief Executive …

Apr 17, 2023 DUBLIN, Ireland and BRIDGEWATER, N.J., April 17, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company’s Board of …See details»

Amarin Reports Second Quarter 2024 Financial Results and …

Jul 31, 2024 DUBLIN and BRIDGEWATER, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today reported financial results for the second quarter …See details»

Amarin Mails Letter to Shareholders Highlighting New Board

Feb 2, 2023 Chairman of Oncopeptides – built and downsized the Company’s U.S. organization over 12 months, following the loss of continued commercialization opportunity ...See details»

Amarin Corporation plc (AMRN) Price & News - Google Finance

Get the latest Amarin Corporation plc (AMRN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.See details»

Amarin to Report Fourth Quarter and Full Year 2023 Financial …

Feb 15, 2024 Go to the investor relations section of the Company's website at www.amarincorp.com Dial in within the United States: 888-506-0062 International dial in: 973 …See details»

Amarin Reports First Quarter 2022 Financial Results and

May 4, 2022 The conference call can be accessed on the investor relations section of the company's website at www.amarincorp.com, or via telephone by dialing 888-506-0062 within …See details»

Amarin Reports Fourth Quarter and Full Year 2023 Financial …

Feb 29, 2024 Amarin Corporation plc-- Company Delivers Total Revenues of $75 Million in the Fourth Quarter and $306 Million for the Full-Year 2023 ---- Reaffirms Year-End 2023 Cash …See details»

Amarin Reports Third Quarter 2023 Financial Results - Yahoo Finance

Nov 1, 2023 Amarin Corporation plc-- Company Reported Total Net Revenues of $66 Million in the Third Quarter 2023 ---- Delivered Positive Cash Flow of $8 Million in the Quarter, Marking …See details»

linkstock.net © 2022. All rights reserved